A round of negotiations that began Monday between the European Union and the U.S. could lead to a trade pact that would affect wide-ranging regulations and patent protections on issues that include pharmaceuticals, highway safety and copyrighted music. Drugmakers want the 12-year protection for biologic drug data that they have in the U.S.

Related Summaries